🟠Stories shaping Asia’s tech and business 🎙 Interviews · 💡 Insights · 📰 Analysis | https://xitter.cf/t.co/nZ1RprkP3Y
Joined September 2025
- Tweets173
- Following0
- Followers25
- Likes226
🎙️ Signals On the Record # 16 | @TynapseAI
Companies are giving #AI agents more responsibility. But how much can they really trust the decisions those agents make?
I spoke with Minseung Kang, co-founder and CEO of South Korean #AIstartup Tynapse,
ICYMI 📰 Signals: APAC #33
Big AI investments, regulatory battles, and a few questions about who will foot the bill.
Here's what we covered this week:
Signals Ventures retweeted
🎉 Intero Biosystems has won Startup Battlefield at TechCrunch Disrupt 2026. 🏆👏
Earlier this week, I covered the startup and its lab-grown human intestines for drug testing. Here’s a closer look at the company and its technology:
techcrunch.com/2026/10/14/in…
Congrats to the team!
Intero Biosystems beat out 199 other Startup Battlefield companies to take home the $100,000 grand prize at TechCrunch Disrupt 2026.
spr.ly/6017BHKXTF
Signals Ventures retweeted
🇺🇸🇨🇳 The US has ordered federal civilian agencies to remove DeepSeek products and certain third-party products and services developed using its technology, citing national security concerns.
More details in my latest piece for TechCrunch ⬇️ techcrunch.com/2026/10/20/us…
Signals Ventures retweeted
The former Google CEO owns about 1% stake in the leading AI lab, Bloomberg reported.
spr.ly/6013BHpcvc
Companies are investing in AI. But are employees convinced? A new study from @NotionHQ reveals a striking divide in Australia: 61% of decision-makers are highly confident in their companies’ AI capabilities, compared with just 26% of knowledge workers. So what’s missing?
Full interview transcript in the comments 👇
patreon.com/SignalsVentures/…
🎙️ Signals On the Record #14
We're living longer. But are we staying healthier? Japanese biotech startup Ekei Labs wants to understand what happens inside our cells as we age.
Its approach is studying tiny chemical marks on DNA that may offer clues about aging and disease. Founder Bilal Kharouni also sees a problem with the rush to use AI in biotech: without the right data, even powerful models have limits.
Could better data eventually help researchers find new treatments? I explored Ekei's technology, ambitions and challenges in my latest Signals story.
📰 Read the full story on Signals. @Substack
🎙️ The full written interview is available to subscribers on @Patreon
🔗 Links in comments ⬇️
🎙️ Signals On the Record #14
We're living longer. But are we staying healthier? Japanese biotech startup Ekei Labs wants to understand what happens inside our cells as we age.
Its approach is studying tiny chemical marks on DNA that may offer clues about aging and disease. Founder Bilal Kharouni also sees a problem with the rush to use AI in biotech: without the right data, even powerful models have limits.
Could better data eventually help researchers find new treatments? I explored Ekei's technology, ambitions and challenges in my latest Signals story.
📰 Read the full story on Signals. @Substack
🎙️ The full written interview is available to subscribers on @Patreon
🔗 Links in comments ⬇️
Signals Ventures retweeted
Heading to TechCrunch Disrupt in SF next week? @NYSEWired is hosting a Happy Hour on Oct 13, sharing in case anyone in my network will be around! Great chance to meet and connect with founders, investors, and others in the tech community. Details & RSVP: luma.com/oeraujqy
Issue #30 of Signals: APAC is out 👋
AI agents are getting phone numbers and wallets. Singapore has a new chip fab. Hard drives are back in the AI
infrastructure conversation. And Japanese robot makers are looking more closely at the U.S.
Plus, a China-linked hacking campaign targeting AI policy circles and plenty more across tech, policy and capital in APAC.
Read Issue #30
